Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin
- 31 July 2007
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 47 (1) , 23-30
- https://doi.org/10.1016/j.jhep.2007.01.027
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Role of Erythrocytes as a Reservoir for Ribavirin and Relationship with Adverse Reactions in the Early Phase of Interferon Combination Therapy for Chronic Hepatitis C Virus InfectionsJournal of Clinical Microbiology, 2006
- Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonrespondersHepatology, 2006
- Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C†Hepatology, 2005
- Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirinJournal of Hepatology, 2005
- SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTSJournal of Hepatology, 2005
- Modelling how ribavirin improves interferon response rates in hepatitis C virus infectionNature, 2004
- Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infectionAIDS, 2004
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- Classification of chronic viral hepatitis: a need for reassessmentPublished by Elsevier ,1991
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976